Example: Heart Attack

Search clinical trials for: Dose decrease

Total 7779 results

NCT03022396

Completed

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 2, 2010

Influenza
NCT02253823

Completed

Multiple Dose Comparison of the Effect of Two Dose Combinations of Tipranavir/Ritonavir (TPV/RTV), on the Pharmacokinetic Characteristics of Efavirenz (Sustiva®) in Healthy Adult Volunteers

Healthy
NCT01483430

Unknown

Effect of Ginseol Kg1 on Blood Pressure Lowering

Prehypertension | Hypertension, Stage I
NCT03562416

Terminated

Continuation of Nintedanib After Single Lung Transplantation in IPF Subjects

Idiopathic Pulmonary Fibrosis | Lung Transplant; Complications
NCT04033250

Unknown

Personalized Colonoscopy Preparation for Patients With Risk Factors for Inadequate Preparation

Inadequate Preparation for Colonoscopy; Personalized Colonoscopy Preparation
NCT05770622

Recruiting

Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2) (VANCAPP)

Infections | Sepsis | Bacteremia
NCT06981806

Not yet recruiting

Phase I Study of Cosibelimab and Balixafortide in Metastatic Pancreatic Ductal Adenocarcinoma

Metastatic Pancreatic Ductal Adenocarcinoma
NCT06028347

Completed

Safety, Reactogenicity, and Immunogenicity Study of a Self-Amplifying MRNA Influenza Vaccine in Healthy Adults

Influenza, Human
NCT07632079

Recruiting

Hypofractionated Definitive Chemoradiotherapy for Oesophageal Cancer (HYROC)

Locally Advanced Esophageal or GE Junction Cancer
NCT06034015

Not yet recruiting

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of APL-1501 Extended Release (ER) Capsules Compared to APL-1202 Immediate Release (IR) Tablets in Healthy Volunteers

Bladder Cancer
NCT05235360

Recruiting

Factorial Trial Testing Guided Thinking Tasks to Optimize a Physical Activity Intervention

Physical Inactivity
NCT03345420

Completed

Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer (NOVEMBER)

Stage 0 Breast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Ductal Breast Carcinoma In Situ
NCT05603312

Completed

A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's Participants

Parkinson's Disease
NCT06446323

Completed

Comparison of Minimal Effective Dose of Sucrose for Pain Relief in Neonates After Minor Procedure

Post Procedural Pain Management in Neonates
NCT05322447

Completed

High-dose L-Carnitine and Diaphragmatic Function Assessed by Ultrasonography in Patients With Respiratory Failure.

Respiratory Failure
NCT05008393

Completed

Efficacy of PJS-539 for Adult Patients With COVID-19. (PJS-539)

Covid19 | COVID-19 Pneumonia
NCT03162874

Completed

Study to Evaluate the Efficacy, Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients (AMBLED)

Parkinson Disease
NCT04098926

Completed

Highly Accelerated Dose-Integrated Radiotherapy in 5 Fractions in Breast Cancer (HAI-5)

Breast Cancer | Radiotherapy
NCT03022422

Completed

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 3, 2011

Influenza
NCT01429493

Unknown

Biological Image Guided Antalgic Stereotactic Body Radiotherapy of Bone Metastases

Bone Metastases
NCT01669512

Completed

Adjuvanting Viral Vectored Malaria Vaccines With Matrix M

Malaria | Matrix M
NCT02251873

Completed

Evaluation of the Pharmacokinetic Interaction of Steady State Tipranavir and Ritonavir or Tipranavir and Ritonavir With Single Dose Didanosine in Healthy Volunteers

Healthy
NCT02092194

Unknown

High Versus Standard Volume Hemodiafiltration in Asia

End-stage Renal Disease
NCT02772718

Completed

An Open-Label Study of XOMA 358 in Patients With Hypoglycemia After Gastric Bypass Surgery (XOMA 358)

Hypoglycemia
NCT03557424

Completed

BEFORE Study, Efficacy of Refigura

Weight Loss | Overweight and Obesity | Efficacy, Self
NCT01649297

Completed

A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy

Diabetes Mellitus, Type 2
NCT02172235

Completed

Relative Bioavailability of Pioglitazone After Co-administration With Different Doses of BI 10773 in Healthy Volunteers

Healthy
NCT07241897

Not yet recruiting

DPP4 Inhibitor Intervention on Post-stroke Cognitive Impairment in Ischemic Stroke Patients With Type 2 Diabetes

Ischemic Stroke | Diabete Mellitus
NCT05996367

Recruiting

Prospective Cohort of Single-dose Radiotherapy for Painful Bone Lesions in Multiple Myeloma

Multiple Myeloma
NCT01207986

Completed

Early Lung Cancer Diagnosis in HIV Infected Population With an Important Smoking History With Low Dose CT: a Pilot Study (EP48 HIV CHEST)

Lung Cancer | Hiv Infection
NCT03142802

Active, not recruiting

Low-Dose CT - Stage I Testicular Cancer

Testicular Cancer
NCT04349176

Terminated

Onabotulinum Dose Comparison in Chronic Migraine Superior to 100 Units?

Chronic Migraine, Headache
NCT04246125

Completed

Patient Skin Dose in Interventional Radiology (DPPRI)

Lung Neoplasms | Liver Neoplasms | Arteriovenous Malformations | Aneurysm | Coronary Occlusion
NCT05716568

Completed

Patient Tailored Contrast Volume for Preoperative CT Angiography of the Aorta

Aortic Aneurysm
NCT04527471

Completed

Pilot Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19

Coronavirus Infection | Covid-19 | SARS-CoV-2
NCT03159377

Completed

Ultra-Low Dose CT Denoising for Lung Nodule Detection

Pulmonary Nodule, Multiple
NCT01830166

Unknown

Focal Therapy for Prostate Cancer - A Pilot Study of Focal Low Dose Rate Brachytherapy (FTPC)

Prostate Cancer
NCT01963195

Unknown

Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy

NSCLC
NCT02993653

Unknown

Intensity-modulated Radiotherapy Protocol in Cervix Cancer

Radiation
NCT00181506

Completed

HI-CHART:Feasibility of High-Dose Accelerated Conformal Radiotherapy

Non-Small-Cell Lung Carcinoma
NCT05150496

Suspended

Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated (CoronaVac®) Vaccine in Healthy Adults in Turkey

COVID-19
NCT02216461

Completed

Safety, Tolerability and Pharmacokinetics of BIBW 2948 BS for HandiHaler® in Healthy Male Volunteers

Healthy
NCT01244867

Completed

Immunogenicity, Safety, Tolerability of a Plant-Made H5 VLP Influenza Vaccine

RNA Virus Infections | Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases
NCT02236052

Completed

Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population

RNA Virus Infections | Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases
NCT01284634

Completed

Study to Evaluate the Effect of GWP42003 on Liver Fat Levels in Participants With Fatty Liver Disease

Fatty Liver
NCT01594125

Completed

Dose Escalation Study of Nintedanib (BIBF 1120) in Japanese Patients With Hepatocellular Carcinoma

Carcinoma, Hepatocellular
NCT05895747

Recruiting

5-HTP and Creatine for Depression R33 Phase

Major Depressive Disorder
NCT04759885

Completed

Efficacy and Safety of mAnnitol in Bowel Preparation During Elective Colonoscopy and Comparison With Moviprep® (SATISFACTION)

Elective Colonoscopy
NCT01328444

Completed

An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444. Study A (COPD)

Pulmonary Disease, Chronic Obstructive
NCT01615796

Completed

Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Repeat IV Doses

Infections, Respiratory Tract

Search clinical trials for: Dose decrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations